Balaji Narasimhan

The Nanovaccine Institute is a consortium of 69 researchers at 21 universities, research institutes, national laboratories, companies, and healthcare coalitions, coordinated by Iowa State University. Their research is an interdisciplinary merger of expertise in immunology, nanotechnology, materials science, clinical science, and social science. They are developing nanovaccines and nanotherapeutics for respiratory infections, neural disorders, tropical diseases, cancer, and veterinary diseases. Their vision is that nanovaccines will revolutionize how we prevent and treat disease.